1. Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J 2019; 53(5): pii: 1900164. https://doi.org/10.1183/13993003.00164-2019;
2. Radovic M, Ristic L, Ciric Z, et al. Changes in respiratory function impairment following the treatment of severe pulmonary tuberculosis - limitations for the underlying COPD detection. Int J Chron Obstruct Pulmon Dis 2016; 11(1): 1307-16. https://doi.org/10.2147/COPD.S106875;
3. Stanković I, Ćirić Z, Radović M. Asthma exacerbations and viruses. Acta Fac Med Naiss 2011; 28(4): 241-4. UDC:616.211-002:616.248;
4. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 2009; 4: 435-59. https://doi.org/10.1146/annurev.pathol.4.110807.092145;
5. Mullerova H, Agusti A, Erqou S, et al. Cardiovascular comorbidity in chronic obstructive pulmonary disease: systematic literature review. Chest 2013; 144: 1163-78 https://doi.org/10.1378/chest.12-2847;